Key result
Interferon did not protect male ICR Swiss mice against the diabetogenic effects of EMCV-D, providing evidence that it does not play a major role in protecting pancreatic beta-cells.
Why the study?
Does interferon play a major role in protecting ICR Swiss male mice against virus-induced diabetes mellitus by EMCV-D?
Does interferon play a major role in protecting ICR Swiss male mice against virus-induced diabetes mellitus by EMCV-D?
Interferon does not play a major role in protecting pancreatic beta-cells against infection by EMCV-D in ICR Swiss mice.
Answers are grounded in this paper and cite their sources.
Does not support major interferon role in this murine model; leaves open relevance to human virus-induced diabetes.
The production of murine diabetes mellitus by the diabetogenic variant of encephalomyocarditis virus (EMCV-D) is prevented in mice preinfected for 24 h with nondiabetogenic virus (EMCV-B). It has been suggested that the protection of the animals is due to the induction of interferon (IFN) by EMCV-B. The present study was done to investigate further the role of IFN in the protection of male ICR Swiss mice against the diabetogenic effects of EMCV-D virus. The results show that this mouse strain is protected only by viable EMCV-B given by either the i.v. or i.p. route of inoculation and that the protection is not abrogated by anti-IFN gamma-globulin. Further, the animals were not protected by either IFN-alpha, IFN- beta, or IFN- alpha/beta at concentrations shown previously to protect mice against the lethal effects of other variants of EMCV. The data provide further evidence that, in the ICR Swiss mouse, IFN does not play a major role in protecting pancreatic beta-cells against infection by EMCV-D.
No takes yet. Share an insight, caveat, or question.
Kaptur et al. (1989) studied Virus-Induced Diabetes Mellitus. Interferon (IFN-alpha, IFN-beta, IFN-alpha/beta) and anti-IFN gamma-globulin was evaluated on Protection against the diabetogenic effects of EMCV-D virus. Interferon did not protect male ICR Swiss mice against the diabetogenic effects of EMCV-D, providing evidence that it does not play a major role in protecting pancreatic beta-cells.
Synapse has enriched 10 related papers. Consider them for comparative context: